91
Growth Score
pts
Heat Score
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
597711
AaviGen GmbH develops heart-targeted AAV-based gene therapies for cardiovascular and cardiopulmonary diseases.
About the Company
AaviGen GmbH develops gene therapies for cardiovascular and cardiopulmonary diseases using a heart-specific adeno-associated viral (AAV) vector platform. The company focuses on curative treatments for heart failure by correcting molecular dysfunctions in cardiomyocytes. Its preclinical pipeline targets pathways such as calcium handling,
mitochondrial energy metabolism, myofilament mechanics, and beta-adrenergic signaling. AaviGen collaborates with academic and industrial partners to develop cardiac AAV capsids in human-relevant models and advance gene therapy candidates like AVG-101 toward clinical development.
